Announcements

We report a case of disseminated histoplasmosis in a renal transplant recipient who presented with a nodular pulmonary lesion and elevated serum and bronchoalveolar lavage (BAL) Aspergillus galatomannan. This almost led to an erroneous diagnosis of invasive aspergillosis since the…
READ MORE →

Dr. Joseph Wheat presenting Thursday, October 3, 2019 at ID Week Session Date: Thursday, October 3, 2019 Session Time: 12:15 PM – 1:30 PM Stop by poster 236 on October 3rd, 12:15PM – 1:30PM, to speak with Dr. Wheat. Event…
READ MORE →

Saturday testing and shipments We now accept specimens on Saturdays and offer Histoplasma antigen and Blastomyces antigen EIA tests on Saturdays.

Updates to our hours of operation: BUSINESS HOURS OF OPERATION: Monday:  8:00am – 5:00pm EST CLINICAL TESTING HOURS OF OPERATION: Monday:  8:00am – 5:00pm EST Tuesday – Friday:  8:00am – 11:00pm EST Saturday:  8:30am – 5:00pm EST CLINICAL CONSULTATION HOURS:…
READ MORE →

At least two Boy Scout campers have been diagnosed with histoplasmosis after staying at Camp Avondale in Baton Rouge, Louisiana.

Indiana Economic Development Corporation Offers economic incentives to MiraVista Diagnostics. This includes $275,000 in tax credits and $50,000 in training grants to hire additional employees and expand its corporate headquarters and diagnostic laboratory in Indianapolis.

MiraVista Diagnostics is participating in 2018 ID Week in San Francisco on October 3-7, 2018. Visit us at booth #1032. Representatives from MiraVista will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal…
READ MORE →

MiraVista Diagnostics is a sponsor and poster presenter at the 2018 Biennial Meeting of the Mycoses Study Group Education and Research Consortium (MSGERC) in Big Sky, Montana on September 25-28, 2018. Poster: Largest Study of Histoplasma Meningitis Debunks Assumptions of…
READ MORE →

August 13-17 is 2018 Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista Diagnostics supports…
READ MORE →

MiraVista Diagnostics is exhibiting at ASM Microbe 2018 in Atlanta on June 7-11, 2018. Please stop by our booth to talk with one of our team members about diagnostic options for serious fungal infections.

April 22-28 is 2018 Medical Laboratory Professionals Week, which is celebrated each year to increase public understanding of and appreciation for laboratory personnel. The theme for this important industry campaign has been “Laboratory Professionals Get Results” since 2010. MiraVista Celebrates 2018…
READ MORE →

National Institutes of Health (NIH) and the State of Indiana Awarded MiraVista Diagnostics More Than $630,000 in Grant Funding to Support Fungal Disease Research to Develop a New Rapid Detection Test for Coccidioidomycosis MiraVista Diagnostics, LLC (MiraVista), a developer of…
READ MORE →

Inside Indiana Business recently featured Indianapolis headquartered MiraVista Diagnostics in its Life Sciences Indiana publication. During the interview, Dr. Lawrence Joseph Wheat shared exciting news about the company’s research initiatives and expansion plans. Read the article below or link directly to…
READ MORE →

MiraVista Diagnostics is attending the South Central Association for Clinical Microbiology’s 2018 SCACM Spring Meeting in French Lick, Indiana on March 7-10, 2018. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →

In compliance with the National Institutes of Health Office of Science Policy (NIH OSP), MiraVista Diagnostics LLC has formed an Institutional Biosafety Committee (IBC) to review, approve and confirm that the company’s research involving recombinant/synthetic DNA complies with NIH guidelines….
READ MORE →

MiraVista Diagnostics is participating in 2017 ID Week in San Diego on October 4-8, 2017. Representatives from the company’s clinical laboratory team will be available to discuss our latest mycology research and menu of diagnostic tests for serious fungal infections….
READ MORE →

August 14–18, 2017, is the first Fungal Disease Awareness Week. CDC and partners have organized this week to highlight the importance of recognizing serious fungal diseases early enough in the course of a patient’s illness to provide life-saving treatment. MiraVista…
READ MORE →

MiraVista Diagnostics is participating in the 2017 Coccidioidomycosis Study Group Symposium on August 11-13 at the Stanford University Medical School. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for serious fungal infections….
READ MORE →

MiraVista Diagnostics is participating in the 2017 Canadian Association for Clinical Microbiology and Infectious Diseases Annual Conference in Toronto on May 3-6, 2017. Representatives from the company’s clinical laboratory will be available to discuss MiraVista’s menu of diagnostic tests for…
READ MORE →